NHI.no
Annonse
Informasjon

Cerebral parese (CP)

Cerebral parese er en skade i hjernen som oppstår i perioden fra tidlig fosterliv til to års alder. Hva slags utslag cerebral parese gir, kommer an på skadens omfang og lokalisasjon i hjernen.

I Norge vil ca. 2 av 1000 barn som fødes, ha eller få Cerebral parese.

Sist oppdatert:

13. des. 2021

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Cerebral parese . Referanselisten for dette dokumentet vises nedenfor

  1. Wimalasundera N, Stevenson VL. Cerebral palsy. Pract Neurol. 2016 Jun;16(3):184-94. Epub 2016 Feb 2. PMID: 26837375. PubMed
  2. Novak I, Morgan C, Adde L, et al. Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment. JAMA Pediatr. 2017 Sep 1;171(9):897-907. Erratum in: JAMA Pediatr. 2017 Sep 1;171(9):919. PMID: 28715518. PubMed
  3. Brandenburg JE, Fogarty MJ, Sieck GC. A Critical Evaluation of Current Concepts in Cerebral Palsy. Physiology (Bethesda). 2019 May 1;34(3):216-229. PMID: 30968751. PubMed
  4. Andersen GL, Raftemo AER, Solheim SO, Aarli Å. Cerebral parese. Generell veileder i pediatri. Norsk barnelegeforening. Sist revidert 2017.
  5. Hollung SJ, Vik T, Lydersen S, Bakken IJ, Andersen GL. Decreasing prevalence and severity of cerebral palsy in Norway among children born 1999 to 2010 concomitant with improvements in perinatal health. Eur J Paediatr Neurol 2018; 22: 814-21. PMID: 29779984 PubMed
  6. Moster D, Wilcox AJ, Vollset SE, Markestad T, Lie RT. Cerebral palsy among term and postterm births. JAMA 2010; 304: 976-82. PMID: 20810375 PubMed
  7. Du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002; 15: 151-157. PubMed
  8. Tollånes MC, Wilcox AJ, Lie RT, Moster D. Familial risk of cerebral palsy: population based cohort study. BMJ 2014; 349: g4294. PMID: 25028249 PubMed
  9. Lie KK, Grøholt E-K, Eskild A. Association of cerebral palsy with Apgar score in low and normal birthweight infants: population based cohort study. BMJ 2010; 341: c4990. PMID: 20929920 PubMed
  10. Flett PJ. Rehabilitation of spasticity and related problems in childhood cerebral palsy. J Paediatr Child Health 2003; 39: 6-14. PubMed
  11. Essex C. Hyperbaric oxygen and cerebral palsy: no proven benefit and potentially harmful. Dev Med Child Neurol 2003; 45: 213-15. PubMed
  12. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000; 13: 133-39. PubMed
  13. Jarvis S, Glinianaia SV, Torrioli M-G, et al. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 2003; 362: 1106-11. PubMed
  14. Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 2000; 42: 816-824. PubMed
  15. Eliasson AC, Krumlinde-Sundholm L, Rösblad B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 2006; 48: 549–54. PMID: 16780622 PubMed
  16. Yude C, Goodman R. Peer problems of 9-11-year-old children with hemiplegia in mainstream school: can these be predicted? Dev Med Child Neurol 1999; 41: 4-8. PubMed
  17. Beckung E, Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol 2002; 44: 309-16. PubMed
  18. Roijen LE, Postema K, Limbeek VJ, Kuppevelt VH. Development of bladder control in children and adolescents with cerebral palsy. Dev Med Child Neurol 2001; 43: 103-07. PMID: 11221896 PubMed
  19. Lofterød B, Terjesen T, Skaaret I. Ganganalyse - nytt diagnostisk hjelpemiddel. Tidsskr Nor Lægeforen 2005; 125: 2014-6. PubMed
  20. Lofterød B, Jahnsen R, Terjesen T. Cerebral parese hos barn - motorisk funksjon og nye behandlingsstrategier. Tidsskr Nor Lægeforen 2006; 126: 2648-51. PubMed
  21. Raftemo AER, Mahendran A, Hollung SJ, et al. Bruk av botulinumtoksin A til barn med cerebral parese. Tidsskr Nor Legeforen 2019. doi:10.4045/tidsskr.18.0554 DOI
  22. Ramstad K, Karstensen AB, Risberg K, Bersaker DK, Sommer FF. Erfaringer med botulinumtoksininjeksjoner mot spastisitet hos barn. Tidsskr Nor Lægeforen 2006; 126: 450-2. PubMed
  23. Delgado MR, Hirtz D, Aisen M, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Neurology 2010; 74: 336-43. PMID: 20101040 PubMed
  24. Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD003469. DOI: 10.1002/14651858.CD003469.pub4 DOI
  25. Wong V. Evidence-based approach of the use of botulinum toxin type A (BTX) in cerebral palsy. Pediatr Rehabil 2003; 6: 85-96. PubMed
  26. Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E. Upper-limb botulinum toxin a injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics 2007; 119: 1149-58. PMID: 17452491 PubMed
  27. Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD004552. DOI: 10.1002/14651858.CD004552.pub2. The Cochrane Library
  28. Hoare BJ, Wallen MA, Thorley MN, Jackman ML, Carey LM, Imms C. Constraint‐induced movement therapy in children with unilateral cerebral palsy. Cochrane Database of Systematic Reviews 2019, Issue 4. Art. No.: CD004149. DOI: 10.1002/14651858.CD004149.pub3. DOI
  29. Myrhaug HT, Østensjø S, Lerdal B et al. Intensiv trening/habilitering til barn med medfødt og ervervet hjerneskade. Rapport fra kunnskapssenteret nr 27, 2008.
  30. Ryan JM, Cassidy EE, Noorduyn SG, O'Connell NE. Exercise interventions for cerebral palsy. Cochrane Database of Systematic Reviews 2017, Issue 6. Art. No.: CD011660. DOI: 10.1002/14651858.CD011660.pub2. DOI
  31. Hodgkinson I, Jindrich ML, Duhaut P, Vadot JP, Metton G, Berard C. Hip pain in 234 non-ambulatory adolescents and young adults with cerebral palsy: a cross-sectional multicentre study. Dev Med Child Neurol 2001; 43: 806-8. PubMed
  32. Graham D, Aquilina K, Cawker S, et al. Single-level selective dorsal rhizotomy for spastic cerebral palsy. J Spine Surg 2016; 2: 195-201. PMID: 27757432 PubMed
  33. Ramstad K, Blom US. Barn med cerebral parese henvist til en tverrfaglig habiliteringsenhet. Tidsskr Nor Lægeforen 2004; 124: 1235-6. Tidsskrift for Den norske legeforening
  34. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004661. DOI: 10.1002/14651858.CD004661.pub3. The Cochrane Library
  35. Strauss D, Shavelle R. Life expectancy of adults with cerebral palsy. Dev Med Child Neurol 1998; 40: 369-75. PubMed
  36. Hutton JL, Pharoah PO. Effects of cognitive, motor, and sensory disabilities on survival in cerebral palsy. Arch Dis Child 2002; 86: 84-89. PubMed
Annonse
Annonse